Sodium‐glucose co‐transporter‐2 inhibitors and susceptibility to COVID‐19: A population‐based retrospective cohort study

Sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors are widely prescribed in people with type 2 diabetes. We aimed to investigate whether SGLT2 inhibitor prescription is associated with COVID‐19, when compared with an active comparator. We performed a propensity‐score‐matched cohort study with active...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Diabetes Obes Metab
Główni autorzy: Sainsbury, Christopher, Wang, Jingya, Gokhale, Krishna, Acosta‐Mena, Dionisio, Dhalla, Samir, Byne, Nathan, Chandan, Joht Singh, Anand, Astha, Cooper, Jennifer, Okoth, Kelvin, Subramanian, Anuradhaa, Bangash, Mansoor N., Taverner, Thomas, Hanif, Wasim, Ghosh, Sandip, Narendran, Parth, Cheng, Kar K., Marshall, Tom, Gkoutos, Georgios, Toulis, Konstantinos, Thomas, Neil, Tahrani, Abd, Adderley, Nicola J., Haroon, Shamil, Nirantharakumar, Krishnarajah
Format: Artigo
Język:Inglês
Wydane: Blackwell Publishing Ltd 2020
Hasła przedmiotowe:
Brief Reports
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537530/
https://ncbi.nlm.nih.gov/pubmed/32991065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14203
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy